Multicenter evaluation of Genechip for detection of multidrug-resistant Mycobacterium tuberculosis

Journal of Clinical Microbiology

Volumn 51, Issue 6, 2013, Pages 1707-1713

  Pang, Yu ^a   Xia, Hui ^a   Zhang, Zhiying ^b   Li, Junchen ^b   Dong, Yi ^b   Li, Qiang ^a   Ou, Xichao ^a   Song, Yuanyuan ^a   Wang, Yufeng ^a   O'Brien, Richard ^c   Kam, Kai Man ^d   Chi, Junying ^a   Huan, Shitong ^e   Chin, Daniel P ^e   Zhao, Yanlin ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b Program for Appropriate Technology in Health   (China)

^c FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS   (Switzerland)

^d DEPARTMENT OF HEALTH   (Hong Kong)

^e BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

ACCURACY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; GENECHIP; HUMAN; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPUTUM SMEAR;

BACTERIOLOGICAL TECHNIQUES; CHINA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM TUBERCULOSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SENSITIVITY AND SPECIFICITY; SPUTUM; TIME FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84878514224     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03436-12     Document Type: Article

References (27)

1. Lonnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, Glaziou P, Raviglione MC. 2010. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 375:1814-1829.
2. World Health Organization. 2012. Global tuberculosis report 2012. World Health Organization, Geneva, Switzerland.
3. Matteelli A, Migliori GB, Cirillo D, Centis R, Girard E, Raviglion M. 2007. Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control. Expert Rev. Anti Infect. Ther. 5:857-871. (Pubitemid 47610948)
4. Nachega JB, Chaisson RE. 2003. Tuberculosis drug resistance: a global threat. Clin. Infect. Dis. 36:S24-S30. (Pubitemid 36140466)
5. Hoek KG, Van Rie A, van Helden PD, Warren RM, Victor TC. 2011. Detecting drug-resistant tuberculosis: the importance of rapid testing. Mol. Diagn. Ther. 15:189-194.
6. Qin YM, Hu CY, Zhu YX. 2008. The ascorbate peroxidase regulated by H2O2 and ethylene is involved in cotton fiber cell elongation by modulating ROS homeostasis. Plant Signal. Behav. 3:194-196.
7. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, Huang L, Caceres T, Mehdiyev R, Raymond L, Whitelaw A, Sagadevan K, Alexander H, Albert H, Cobelens F, Cox H, Alland D, Perkins MD. 2011. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 377:1495-1505.
8. Van Rie A, Page-Shipp L, Scott L, Sanne I, Stevens W. 2010. Xpert((R)) MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource- limited countries: hype or hope? Expert Rev. Mol. Diagn. 10:937-946.
9. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, Milovic A, Jones M, O'Brien SM, Persing DH, Ruesch-Gerdes S, Gotuzzo E, Rodrigues C, Alland D, Perkins MD. 2010. Rapid molecular detection of tuberculosis and rifampin resistance. N. Engl. J. Med. 363:1005-1015.
10. Farmer P, Bayona J, Becerra M, Furin J, Henry C, Hiatt H, Kim JY, Mitnick C, Nardell E, Shin S. 1998. The dilemma of MDR-TB in the global era. Int. J. Tuberc. Lung Dis. 2:869-876. (Pubitemid 28539468)
11. Van Rie A, Enarson D. 2006. XDR tuberculosis: an indicator of publichealth negligence. Lancet 368:1554-1556. (Pubitemid 44691898)
12. Ajbani K, Shetty A, Mehta A, Rodrigues C. 2011. Rapid diagnosis of extensively drug-resistant tuberculosis by use of a reverse line blot hybridization assay. J. Clin. Microbiol. 49:2546-2551.
13. World Health Organization. 2008. Anti-tuberculosis drug resistance in the world: fourth global report. WHO/HTM/TB publication no. 2008.394. World Health Organization, Geneva, Switzerland.
14. Guo Y, Zhou Y, Wang C, Zhu L, Wang S, Li Q, Jiang G, Zhao B, Huang H, Yu H, Xing W, Mitchelson K, Cheng J, Zhao Y. 2009. Rapid, accurate determination of multidrug resistance in M. tuberculosis isolates and sputum using a biochip system. Int. J. Tuberc. Lung Dis. 13:914-920.
15. Ling DI, Zwerling AA, Pai M. 2008. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur. Respir. J. 32:1165-1174.
16. Almeida Da Silva PE, Palomino JC. 2011. Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs. J. Antimicrob. Chemother. 66:1417-1430.
17. Ramaswamy S, Musser JM. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. 79:3-29. (Pubitemid 29050434)
18. Hazbon MH, Brimacombe M, Bobadilla del Valle M, Cavatore M, Guerrero MI, Varma-Basil M, Billman-Jacobe H, Lavender C, Fyfe J, Garcia-Garcia L, Leon CI, Bose M, Chaves F, Murray M, Eisenach KD, Sifuentes-Osornio J, Cave MD, Ponce de Leon A, Alland D. 2006. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 50:2640-2649. (Pubitemid 44198682)
19. Zhang Y, Yew WW. 2009. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 13:1320-1330.
20. O'Grady J, Maeurer M, Mwaba P, Kapata N, Bates M, Hoelscher M, Zumla A. 2011. New and improved diagnostics for detection of drugresistant pulmonary tuberculosis. Curr. Opin. Pulm. Med. 17:134-141.
21. Theron G, Pooran A, Peter J, van Zyl-Smit R, Kumar Mishra H, Meldau R, Calligaro G, Allwood B, Sharma SK, Dawson R, Dheda K. 2012. Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting? Eur. Respir. J. 40:161-168.
22. Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, Xia H, Zhou Y, Li Q, Ou X, Pang Y, Song Y, Zhao B, Zhang H, He G, Guo J, Wang Y. 2012. National survey of drug-resistant tuberculosis in China. N. Engl. J. Med. 366:2161-2170.
23. Malhotra S, Cook VJ, Wolfe JN, Tang P, Elwood K, Sharma MK. 2010. A mutation in Mycobacterium tuberculosis rpoB gene confers rifampin resistance in three HIV-TB cases. Tuberculosis (Edinb.) 90:152-157.
24. Chen X, Ma Y, Jin Q, Jiang GL, Li CY, Wang Q. 2005. Characterization of the katG, inhA, ahpC, kasA, and oxyR gene mutations in isoniazidresistant and susceptible strain of Mycobacterium tuberculosis by automated DNA sequencing. Zhonghua Jie He He Hu Xi Za Zhi 28:250-253. (In Chinese.) (Pubitemid 44763470)
25. Dalla Costa ER, Ribeiro MO, Silva MS, Arnold LS, Rostirolla DC, Cafrune PI, Espinoza RC, Palaci M, Telles MA, Ritacco V, Suffys PN, Lopes ML, Campelo CL, Miranda SS, Kremer K, da Silva PE, Fonseca Lde S, Ho JL, Kritski AL, Rossetti ML. 2009. Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America. BMC Microbiol. 9:39. doi:10.1186/1471-2180-9-39.
26. Siu GK, Zhang Y, Lau TC, Lau RW, Ho PL, Yew WW, Tsui SK, Cheng VC, Yuen KY, Yam WC. 2011. Mutations outside the rifampicin resis-tance- determining region associated with rifampicin resistance in Mycobacterium tuberculosis. J. Antimicrob. Chemother. 66:730-733.
27. Minh NN, Van Bac N, Son NT, Lien VT, Ha CH, Cuong NH, Mai CT, Le TH. 2012. Molecular characteristics of rifampin-and isoniazidresistant Mycobacterium tuberculosis strains isolated in Vietnam. J. Clin. Microbiol. 50:598-601.